flow trial semaglutide ppt FLOW-Trial-Shadow SELECT Trial

Common dose terms include Wellbutrin XL 150 mg and Wellbutrin XL 300 mg

Led by Thomas Wadden, PhD, a professor at the University of Pennsylvania, the research reviewed findings from the Semaglutide Treatment Effect in People with Obesity (STEP) trials, which played a key role in the FDAs approval of semaglutide injections

Factors That Influence Your Individual Weight Loss Timeline Your genetic makeup plays a significant role in how your body responds to semaglutide

Important considerations include: Individual responses vary considerablynot all patients experience reduced cravings Changes in food preferences may reflect general appetite suppression rather than specific effects on sugar craving Psychological and behavioural factors continue to influence eating patterns Long-term sustainability of any craving reduction after medication discontinuation is uncertain Patients should not rely solely on medication to manage sugar intake

Others find they can stop medication after making substantial lifestyle changes, though this requires ongoing commitment